# Treatment of HCV-Infected Recent Injection Drug Users in U.S. Liver Clinics

> **NCT05895448** · PHASE4 · UNKNOWN · sponsor: **Center For Hepatitis C, Atlanta, GA** · enrollment: 125 (estimated)

## Conditions studied

- Chronic Hepatitis C
- People Who Inject Drugs

## Interventions

- **DRUG:** velpatasvir and sofosbuvir once daily for 12 weeks (brand or branded generic) .

## Key facts

- **NCT ID:** NCT05895448
- **Lead sponsor:** Center For Hepatitis C, Atlanta, GA
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2023-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05895448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05895448, "Treatment of HCV-Infected Recent Injection Drug Users in U.S. Liver Clinics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05895448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*